Evidence map›Paper›PMID 22955875›Full record

ArticleRheumatology international2013

IL-23A, IL-23R, IL-17A and IL-17R polymorphisms in different psoriatic arthritis clinical manifestations in the northern Italian population.

Maria Grazia Catanoso, Luigi Boiardi, Pierluigi Macchioni, Paolo Garagnani, Marco Sazzini, Sara De Fanti, Enrico Farnetti, Bruno Casali, Ilaria Chiarolanza, Davide Nicoli and 2 more

Registry-linked trialOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03149900 (Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx), which is not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03149900 completednot on this mapstarted 2016, after this paper: background citation

Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients

TypeobservationalSponsorDiamant ThaciRan2016 to 2019Enrolled40ConditionsPsoriasis VulgarisArmsSecukinumab
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Association between IL-17A, IL-17F and IL-17RA gene polymorphisms and susceptibility to psoriasis and psoriatic arthritis: a meta-analysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Evaluation of the relationship ofPostepy dermatologii i alergologii · 2021
    Article
  8. Review
  9. Review
  10. Article
  11. Association ofPharmacogenomics and personalized medicine · 2020
    Article
  12. Review
  13. Article
  14. Influence ofMediators of inflammation · 2018
    Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Maria Grazia CatanosoRheumatology Unit, Arcispedale S Maria Nuova, IRCCS, Viale Risorgimento n 80, 42100 Reggio Emilia, Italy.
Luigi Boiardi
Pierluigi Macchioni
Paolo Garagnani
Marco Sazzini
Sara De Fanti
Enrico Farnetti
Bruno Casali
Ilaria Chiarolanza
Davide Nicoli
Donata Luiselli
Carlo Salvarani
Istituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the genetic variability of IL-17A, IL17-RA, IL-23A and IL-23R genes on an in-depth phenotypically characterized northern Italian Psoriatic arthritis (PsA) case-control cohort, in search for associations specific to different PsA clinical sub-phenotypes. We examined 118 patients with PsA according to CASPAR criteria (mean age 57 ± 13, female 38.4 %, mean disease duration 13.9 ± 8.6 years, peripheral disease 83.8 %, axial manifestations 34.5 %, radiological erosive disease 49 %) compared with 248 controls of the same ethnic origin matched for age and sex. The presence of axial disease was defined by the clinical axial involvement and/or the presence of radiological alteration consistent with spondyloarthropathy according to New York criteria. The presence of peripheral disease (arthritis and/or enthesitis) was defined only on clinical basis. A total of 40 SNPs, mapping within the genes mentioned above, were genotyped in both groups and used to perform association analyses by subdividing the PsA sample into subgroups according to different clinical manifestations on the basis of axial and peripheral involvements. No differences between patients and controls were found in the distribution of the IL-17A, IL17-RA, IL-23A and IL-23R genes allelic variants. Comparing patients with axial disease versus those without, we found that axial manifestations were significantly associated with the presence of IL-23R rs12401432 GG homozygosity (26.8 % vs. 5.3 %, p corr = 0.019, OR 2.63 [95 % CI 1.13-6.16]). No differences in distribution of the allelic variants were found comparing patients with versus those without peripheral disease or patients with versus without radiological peripheral erosions. In PA patients of northern Italian origin, IL-17A, IL17-RA, IL-23A and IL-23R genes allelic variants are not associated with disease susceptibility. However, a strong association with the IL-23RA rs12401432 GG genotype is associated with axial involvement of the disease.

Indexed as

Polymorphism, Single NucleotideAdultAgedArthritis, PsoriaticCase-Control StudiesChi-Square DistributionFemaleGene FrequencyGenetic Predisposition to DiseaseHaplotypesHumansInterleukin-17Interleukin-23 Subunit p19ItalyLinkage DisequilibriumLogistic ModelsIL17A protein, humanIL17RA protein, humanIL23A protein, humanIL23R protein, humanInterleukin-17Interleukin-23 Subunit p19Receptors, InterleukinReceptors, Interleukin-17

Identifiers

PMID22955875
OpenAlexW2092264911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.